Literature DB >> 30280423

Differential expression of interferon-induced genes and other tissue-based biomarkers in acute graft-versus-host disease vs. lupus erythematosus in skin.

J S Lehman1,2, S Dasari3, S S Damodaran1, R A El-Azhary1, L E Gibson1,2, S K Hashmi4, W J Hogan4, S J Kenderian4, M S Patnaik4, M R Litzow4, H M Lazarus5, A Meves1.   

Abstract

BACKGROUND: In both acute graft-versus-host disease (GVHD) and lupus erythematosus (LE), the patient's own tissues are subjected to immunological assault via complex mechanisms influenced by interferon (IFN) and other cytokines. Although not typically confused clinically, these entities have overlapping histopathological findings in the skin. AIM: To assess whether GVHD can be differentiated from LE using molecular methods on skin specimens.
METHODS: We developed a quantitative reverse transcription PCR assay based on previously identified tissue-based biomarkers of cutaneous GVHD, and compared gene expression in GVHD with that in LE.
RESULTS: Both entities showed robust expression of IFN-induced genes and of genes encoding proteins involved in antigen presentation, cell signalling and tissue repair. Levels of gene expression differed significantly in GVHD compared with LE, particularly those of IFN-induced genes such as MX1, OAS3, TAP1 and STAT3 (P < 0.01). Three logistic regression models could differentiate the two entities with a high degree of certainty (receiver operating characteristic area under the curve of 1.0).
CONCLUSION: The study demonstrates the feasibility of distinguishing between microscopically similar inflammatory dermatoses using tissue-based molecular techniques.
© 2018 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30280423      PMCID: PMC6445793          DOI: 10.1111/ced.13759

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  23 in total

1.  Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions.

Authors:  L Farkas; K Beiske; F Lund-Johansen; P Brandtzaeg; F L Jahnsen
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Antilaminin-1 antibodies in cutaneous lupus erythematosus patients.

Authors:  M Caproni; E Antiga; C Cardinali; E Del Bianco; Paolo Fabbri
Journal:  Lupus       Date:  2009-08       Impact factor: 2.911

3.  Type I-IFNs control GVHD and GVL responses after transplantation.

Authors:  Renee J Robb; Ellen Kreijveld; Rachel D Kuns; Yana A Wilson; Stuart D Olver; Alistair L J Don; Neil C Raffelt; Nicole A De Weerd; Katie E Lineburg; Antiopi Varelias; Kate A Markey; Motoko Koyama; Andrew D Clouston; Paul J Hertzog; Kelli P A Macdonald; Geoffrey R Hill
Journal:  Blood       Date:  2011-06-30       Impact factor: 22.113

4.  Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays.

Authors:  Tamotsu Ichiba; Takanori Teshima; Rork Kuick; David E Misek; Chen Liu; Yuichiro Takada; Yoshinobu Maeda; Pavan Reddy; Debra L Williams; Samir M Hanash; James L M Ferrara
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

5.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.

Authors:  Emily C Baechler; Franak M Batliwalla; George Karypis; Patrick M Gaffney; Ward A Ortmann; Karl J Espe; Katherine B Shark; William J Grande; Karis M Hughes; Vivek Kapur; Peter K Gregersen; Timothy W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

6.  Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib.

Authors:  Kai Sun; Lisbeth A Welniak; Angela Panoskaltsis-Mortari; Matthew J O'Shaughnessy; Haiyan Liu; Isabel Barao; William Riordan; Raquel Sitcheran; Christian Wysocki; Jonathan S Serody; Bruce R Blazar; Thomas J Sayers; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

7.  Cutaneous lichenoid graft-versus-host disease mimicking lupus erythematosus.

Authors:  R Goiriz; P F Peñas; Y Delgado-Jiménez; J Fernández-Herrera; M Aragüés-Montañés; J Fraga; A García-Díez
Journal:  Lupus       Date:  2008-06       Impact factor: 2.911

Review 8.  An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis".

Authors:  Joerg Wenzel; Thomas Tüting
Journal:  J Invest Dermatol       Date:  2008-04-17       Impact factor: 8.551

Review 9.  The pathophysiology of acute graft-versus-host disease.

Authors:  James L M Ferrara; Kenneth R Cooke; Takanori Teshima
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

10.  The lupus band: do the autoantibodies target collagen VII?

Authors:  A M Alahlafi; P Wordsworth; F Wojnarowska
Journal:  Br J Dermatol       Date:  2004-03       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.